|
|
||||||||
G. A. Spinas is Professor, Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, CH-8091 Zürich, Switzerland.
In pancreatic islets, nitric oxide (NO) produced on exposure to cytokines mediates ß-cell injury leading to diabetes mellitus. On the other hand, L-arginine-derived NO may participate in the signal transduction pathway of physiological insulin secretion. This review focuses on the dual role of NO as a mediator of physiological and pathophysiological processes in pancreatic islets.
This article has been cited by other articles:
![]() |
C. S. Nunemaker, D. G. Buerk, M. Zhang, and L. S. Satin Glucose-induced release of nitric oxide from mouse pancreatic islets as detected with nitric oxide-selective glass microelectrodes Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E907 - E912. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Henningsson, A. Salehi, and I. Lundquist Role of nitric oxide synthase isoforms in glucose-stimulated insulin release Am J Physiol Cell Physiol, July 1, 2002; 283(1): C296 - C304. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Marchetti, R. Lupi, M. Federici, L. Marselli, M. Masini, U. Boggi, S. Del Guerra, G. Patane, S. Piro, M. Anello, et al. Insulin Secretory Function Is Impaired in Isolated Human Islets Carrying the Gly972->Arg IRS-1 Polymorphism Diabetes, May 1, 2002; 51(5): 1419 - 1424. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |